• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • France

FRANCE - Siparex Croissance clocks up good performance for 2005

  • Fay
  • 06 March 2006
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Sigefi Private Equity’s listed private equity vehicle, Siparex Croissance, has today announced its performance in 2005. The fund, which is quoted on Eurolist’s C compartment, recorded its best performance in five years for parent company net income - amounting to EUR 8.9m, versus EUR 7.8m in 2004 and EUR 5.1m in 2003. Net capital gains for the year rose by 27% to EUR 15.5m. Consolidated net income, calculated according to IFRS standards, totalled EUR 8.4m, versus EUR 14.7m in 2004. IFRS net income in 2004 benefited from exit prices greater than the valuations on 31 December 2003, with a difference of EUR 6.9m, as well as a EUR 9.3m increase in unrealised capital gains. Of that amount, EUR 7.8m was realised during the course of 2005 and was not reflected in IFRS net income for that year. Nevertheless, the value of the portfolio increased by EUR 7.7m in 2005, after additions to allowances.

Consolidated shareholders’ equity attributable to the Group at 31 December 2005 amounted to EUR 136.29m, corresponding to net consolidated shareholders’ equity of EUR 29.63 per share, up by 5% from 31 December 2004. The 31 December 2005 share price (EUR 30.45) was 2.7% higher than net consolidated shareholders’ equity per share, but there was no longer a differential compared with the 27 February 2006 share price (EUR 29.60). After the capital reduction following the simplified share buy-back offer that ended on 6 January 2006, net consolidated shareholders’ equity per share stood at EUR 29.45.

The shareholders’ meeting on 25 April 2006 will be asked to distribute a dividend of EUR 8.5m, representing virtually all parent company income. This dividend of EUR 2.14 per share, or EUR 2.354 for shares eligible for the loyalty bonus, is 40% higher than for 2004. This change reflects both the 22% increase in the total dividend distribution and the EPS enhancing impact of the January 2006 capital reduction (18%). The pretax yields are 7.23% and 7.95%, respectively, regarding the 27 February 2006 share price.

Thanks to the tax status of SCR venture capital companies, individual shareholders are entitled to receive a tax exemption on dividends, and, for shares acquired since 1 January 2001, on capital gains from disposals. To benefit from this tax treatment, which considerably increases the yield, shareholders must hold their shares for a period of five years and reinvest their dividends in the company during the same period.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • France

More on France

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Mergermarket
Letter from the editor: Unquote is moving to Mergermarket

Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers

  • Industry
  • 30 August 2023
Pensions administration software providers
IK Investment-backed Eres expected to hit the auction block by 2024

French employee savings distribution and management firm could be valued at a few hundred million euros

  • Exits
  • 24 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013